The Therapeutic Potential of Sigma (σ ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|7|884-901

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.7, 2012-03, pp. : 884-901

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent progress in 5-HT7 receptors: potential treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik   Isaac Methvin   Xin Tao  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1009-1027

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Therapeutic Relevance of Adenosine A2B and A2A Receptors in the Central Nervous System

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 6, 2012-09 ,pp. : 664-674

Bentham Science Publishers

Access to resources Recommend Favorite

TRPV1 Receptors in the Central Nervous System: Potential for Previously Unforeseen Therapeutic Applications

By  

Current Pharmaceutical Design, Vol. 14, Iss. 1, 2008-01 ,pp. : 42-54

Bentham Science Publishers

Access to resources Recommend Favorite

Sigma receptors: biology and therapeutic potential

By Guitart Xavier   Codony Xavier   Monroy Xavier  

Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. : 301-319

Springer Publishing Company

Access to resources Recommend Favorite